Nordson (NASDAQ:NDSN) reported Q4 CY2025 results that exceeded Wall Street’s revenue expectations, with sales up 8.8% year-on-year to $669.5 million. The company’s adjusted EPS of $2.37 was in line with analyst estimates, and management provided better-than-expected guidance for both next quarter’s revenue and full-year revenue and adjusted EPS. Despite the revenue beat and raised guidance, the article notes that organic revenue missed and EBITDA fell short of estimates, leading to a “weaker quarter” despite the initial stock price increase.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Nordson (NASDAQ:NDSN) Exceeds Q4 CY2025 Expectations
Nordson (NASDAQ:NDSN) reported Q4 CY2025 results that exceeded Wall Street’s revenue expectations, with sales up 8.8% year-on-year to $669.5 million. The company’s adjusted EPS of $2.37 was in line with analyst estimates, and management provided better-than-expected guidance for both next quarter’s revenue and full-year revenue and adjusted EPS. Despite the revenue beat and raised guidance, the article notes that organic revenue missed and EBITDA fell short of estimates, leading to a “weaker quarter” despite the initial stock price increase.